Tag: Reliv
Reliv International 2018 Revenue Down 14% To $36 Million
March 30, 2019
Reliv International, Inc. (NASDAQ:RELV), a maker of nutritional supplements that promote optimal health, today reported its financial results for the fourth quarter and full year of 2018. Fourth-Quarter Results Reliv reported net sales of $9.3 million ...
Read more
Reliv Q2 Sales Down 10% To 10 Million
August 14, 2017
Reliv reported net sales of $10.0 million for the second quarter of 2017 compared with net sales of $11.1 million in the second quarter of 2016. Net sales in the United States decreased to $7.5 million ...
Read more
Reliv 2016 Q4 Sales Down 12% To $10.6 Million
March 30, 2017
Reliv International, Inc. (NASDAQ: RELV), a maker of nutritional supplements that promote optimal health, today reported its financial results for the fourth quarter and full year of 2016. Fourth-Quarter Results Reliv reported net sales of ...
Read more
Reliv Reports Q2 Sales Down 12.9% To $11.1 Million
August 15, 2016
Reliv International, Inc., a maker of nutritional supplements that promote optimal health, today reported its financial results for the second quarter of 2016. Reliv reported net sales of $11.1 million for the second quarter of ...
Read more
Reliv Reports 2016 Q1 Results – Net Sales Down 10.7% To $13 Million
May 17, 2016
Reliv International, Inc. (NASDAQ: RELV), a maker of nutritional supplements that promote optimal health, recently reported its financial results for the first quarter of 2016. Reliv reported net sales of $13.0 million for the first ...
Read more
Reliv Reports Q4 And Full Year 2015 Financial Results
April 23, 2016
Reliv International, Inc., a maker of nutritional supplements that promote optimal health, today reported its financial results for the fourth quarter and full year of 2015. Reliv reported net sales of $12.3 million for the ...
Read more
Reliv Q4 Sales Down 12% To $12.3 Million
March 26, 2016
Reliv International, Inc. (NASDAQ: RELV), a maker of nutritional supplements that promote optimal health, today reported its financial results for the fourth quarter and full year of 2015. Fourth-Quarter Results Reliv reported net sales of ...
Read more
Reliv Receives Expanded Patent For LunaRich
August 20, 2015
Reliv International, Inc. (NASDAQ: RELV), a maker of nutritional supplements that promote optimal health, today announced that the U.S. Patent and Trademark Office has issued an expanded patent for LunaRich, Reliv's exclusive nutritional ingredient. The ...
Read more
Reliv 2015 Q2 – Net Sales Down 14% To $12.4 Million
August 15, 2015
Reliv International, Inc., a maker of nutritional supplements that promote optimal health reported its financial results for the second quarter of 2015. Net sales for the quarter were $12.4 million, a 14.0 percent decrease from ...
Read more
Reliv Earns New Research Patent
June 25, 2015
Reliv International, a maker of nutritional supplements that promote optimal health, recently announced that the Commonwealth of Australia Patents Office has issued a Certificate of Patent to Dr. Alfredo Galvez, chief scientific officer at SL ...
Read more
Reliv 2015 Q1 Net Sales Up 7.4% To $14.8 Million
May 5, 2015
Reliv International, Inc. (NASDAQ: RELV), a maker of nutritional supplements that promote optimal health, reported its financial results for the first quarter of 2015. Reliv reported net sales of $14.8 million for the first quarter ...
Read more
Reliv Down 19.8% In Q4 – 2014 To $14.1Million
March 11, 2015
Reliv International, Inc, a maker of nutritional supplements that promote optimal health, today reported its financial results for the fourth quarter and full year of 2014. Reliv reported net sales of $14.1 million for the ...
Read more